<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">tumors</journal-id><journal-title-group><journal-title xml:lang="ru">Malignant tumours</journal-title><trans-title-group xml:lang="en"><trans-title>Malignant tumours</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2224-5057</issn><issn pub-type="epub">2587-6813</issn><publisher><publisher-name>Rosoncoweb</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18027/2224-5057-2025-052</article-id><article-id custom-type="elpub" pub-id-type="custom">tumors-1496</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ СЛУЧАИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL NOTES</subject></subj-group></article-categories><title-group><article-title>Эпителиоидная гемангиоэндотелиома лёгкого: клинический случай</article-title><trans-title-group xml:lang="en"><trans-title>Epithelioid hemangioendothelioma of the lung: a clinical case</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-4164-2372</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Туромша</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Turomsha</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Алеся Николаевна Туромша </p><p>197372 Санкт-Петербург, ул. Ильюшина, 4 / 1 </p></bio><bio xml:lang="en"><p>Alesya Nikolaevna Turomsha</p><p>4/1 Ilyushina St., Saint Petersburg 197372</p></bio><email xlink:type="simple">turomsha-an@avaclinic.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7930-8048</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Протасова</surname><given-names>А. Э.</given-names></name><name name-style="western" xml:lang="en"><surname>Protasova</surname><given-names>A. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Анна Эдуардовна Протасова </p><p>197372 Санкт-Петербург, ул. Ильюшина, 4 / 1 </p><p>197341 СанктПетербург, ул. Аккуратова, 2 </p><p>199034 Санкт-Петербург, Университетская набережная, 7–9 </p></bio><bio xml:lang="en"><p>Anna Eduardovna Protasova</p><p>4/1 Ilyushina St., Saint Petersburg 197372</p><p>2 Akkuratova St., Saint Petersburg 197341</p><p>7-9 Universitetskaya Emb., Saint Petersburg 19903</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-4392-0700</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шеремет</surname><given-names>М. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Sheremet</surname><given-names>M. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Марина Юрьевна Шеремет </p><p>197372 Санкт-Петербург, ул. Ильюшина, 4 / 1</p></bio><bio xml:lang="en"><p>Marina Yurevna Sheremet</p><p>4/1 Ilyushina St., Saint Petersburg 197372</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ООО «АВА-ПЕТЕР»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>AVA-PBTBR LLC</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ООО «АВА-ПЕТЕР» ; ФГБУ «Национальный медицинский исследовательский центр им. В. А. Алмазова» Минздрава России ; ФБОУ ВО «Санкт-Петербургский государственный университет»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>AVA-PBTBR LLC ;  V. A. Almazov National Medical Research Centre, Ministry of Health of Russia ; Saint Petersburg State University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>30</day><month>10</month><year>2025</year></pub-date><volume>15</volume><issue>3</issue><fpage>61</fpage><lpage>67</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Туромша А.Н., Протасова А.Э., Шеремет М.Ю., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Туромша А.Н., Протасова А.Э., Шеремет М.Ю.</copyright-holder><copyright-holder xml:lang="en">Turomsha A.N., Protasova A.E., Sheremet M.Y.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.malignanttumors.org/jour/article/view/1496">https://www.malignanttumors.org/jour/article/view/1496</self-uri><abstract><p>Эпителиоидная гемангиоэндотелиома (ЭГЭ) — крайне редкая сосудистая саркома, характеризующаяся уникальными морфологическими и молекулярными признаками. Заболеваемость составляет около 1 случая на миллион человек. В данной публикации представлены данные клинических случаев с различными локализациями ЭГЭ, опубликованных в отечественной литературе. Представлен наш уникальный клинический пример ЭГЭ лёгкого, сопровождавшийся значительными трудностями гистологической верификации. В работе проанализированы особенности диагностики данного заболевания, а также представлены данные о проведённом лечении и его результатах.</p></abstract><trans-abstract xml:lang="en"><p>Epithelioid hemangioendothelioma (EGE) is an extremely rare vascular sarcoma characterized by unique morpho­logical and molecular features. The incidence is about 1 case per million people. This publication presents data on clinical cases with various localizations of EGE published in the Russian literature. Our unique clinical example of lung EGE is presented, which was accompanied by significant difficulties in histological verification. The paper analyzes the features of the diagnosis of this disease, as well as presents data on the treatment and its results.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>Эпителиоидная гемангиоэндотелиома</kwd><kwd>эпителиоидная гемангиоэндотелиома лёгкого</kwd><kwd>сосудистые опухоли</kwd><kwd>компьютерно-томографические признаки эпителиоидной гемангиоэндотелиомы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Epithelioid hemangioendothelioma</kwd><kwd>epithelioid hemangioendothelioma of the lung</kwd><kwd>vascular tumors</kwd><kwd>computed tomography signs of epithelioid hemangioendothelioma</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Liu Z., Не S. Epithelioid hemangioendothelioma: incidence, mortality, prognostic factors, and survival analysis using the surveillance, epidemiology, and end results database. J Oncol 2022;2022:2349991. https://doi.org/10.1155/2022/2349991</mixed-citation><mixed-citation xml:lang="en">Liu Z., Не S. Epithelioid hemangioendothelioma: incidence, mortality, prognostic factors, and survival analysis using the surveillance, epidemiology, and end results database. J Oncol 2022;2022:2349991. https://doi.org/10.1155/2022/2349991</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Amin R.M.S., Hiroshima K., Kokubo T., et al. Risk factors and independent predictors of survival in patients with pulmonary epithelioid haemangioendothelioma. Review of the literature and a case report. Respirology 2006;ll(6):818-825. https://doi.Org/10.llll/j.1440-1843.2006.00923.x</mixed-citation><mixed-citation xml:lang="en">Amin R.M.S., Hiroshima K., Kokubo T., et al. Risk factors and independent predictors of survival in patients with pulmonary epithelioid haemangioendothelioma. Review of the literature and a case report. Respirology 2006;ll(6):818-825. https://doi.Org/10.llll/j.1440-1843.2006.00923.x</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Tsuchihashi K., Baba E. Epithelioid hemangioendothelioma-its history, clinical features, molecular biology and current therapy.jpnj Clin Oncol 2024;54(7):739-747. https://doi.org/10.1093/jjco/hyae037</mixed-citation><mixed-citation xml:lang="en">Tsuchihashi K., Baba E. Epithelioid hemangioendothelioma-its history, clinical features, molecular biology and current therapy.jpnj Clin Oncol 2024;54(7):739-747. https://doi.org/10.1093/jjco/hyae037</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Errani C., Zhang L., Sung Y.S., et al. A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites. Genes Chromosomes Cancer 2011;50(8):644-653. https://doi.org/10.1002/gcc.20886</mixed-citation><mixed-citation xml:lang="en">Errani C., Zhang L., Sung Y.S., et al. A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites. Genes Chromosomes Cancer 2011;50(8):644-653. https://doi.org/10.1002/gcc.20886</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Weiss S.W., Enzinger F.M. Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Cancer 1982;50(5):970-81. https://doi.org/10.1002/1097-0142(19820901)50:5&lt;970::aid-cncr2820500527&gt;3.0.co;2-z</mixed-citation><mixed-citation xml:lang="en">Weiss S.W., Enzinger F.M. Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Cancer 1982;50(5):970-81. https://doi.org/10.1002/1097-0142(19820901)50:5&lt;970::aid-cncr2820500527&gt;3.0.co;2-z</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Travis W.D., Brambilla E., Nicholson A.G., et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol 2015;10(9):1243—1260. https://doi.org/10.1097/JTO.0000000000000630</mixed-citation><mixed-citation xml:lang="en">Travis W.D., Brambilla E., Nicholson A.G., et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol 2015;10(9):1243—1260. https://doi.org/10.1097/JTO.0000000000000630</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Mentzel T., Beham A., Calonje E., et al. Epithelioid hemangioendothelioma of skin and soft tissues: clinicopathologic and immunohistochemical study of 30 cases. Am J Surg Pathol 1997;21(4):363—374. https://doi.org/10.1097/00000478-199704000-00001</mixed-citation><mixed-citation xml:lang="en">Mentzel T., Beham A., Calonje E., et al. Epithelioid hemangioendothelioma of skin and soft tissues: clinicopathologic and immunohistochemical study of 30 cases. Am J Surg Pathol 1997;21(4):363—374. https://doi.org/10.1097/00000478-199704000-00001</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Hornick J.L., Dal C.P., Fletcher C.D. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma. AmJ Surg Pathol 2009;33(4):542—550. https://doi.org/10.1097/PAS.0b013e3181882c54</mixed-citation><mixed-citation xml:lang="en">Hornick J.L., Dal C.P., Fletcher C.D. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma. AmJ Surg Pathol 2009;33(4):542—550. https://doi.org/10.1097/PAS.0b013e3181882c54</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Lau K., Massad M., Poliak C., et al. Clinical patterns and outcome in epithelioid hemangioendothelioma with or without pulmonary involvement: insights from an internet registry in the study of a rare cancer. Chest 2011;140:1312-1318. https://doi.org/10.1378/chest.ll-0039</mixed-citation><mixed-citation xml:lang="en">Lau K., Massad M., Poliak C., et al. Clinical patterns and outcome in epithelioid hemangioendothelioma with or without pulmonary involvement: insights from an internet registry in the study of a rare cancer. Chest 2011;140:1312-1318. https://doi.org/10.1378/chest.ll-0039</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Tong D., Constantinidou A., Engelmann B., et al. The role of local therapy in multi-focal epithelioid haemangioendothelioma. Anticancer Res 2019;39(9):4891-4896. https://doi.org/10.21873/anticanres.13675</mixed-citation><mixed-citation xml:lang="en">Tong D., Constantinidou A., Engelmann B., et al. The role of local therapy in multi-focal epithelioid haemangioendothelioma. Anticancer Res 2019;39(9):4891-4896. https://doi.org/10.21873/anticanres.13675</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Frezza A.M., Napolitano A., Miceli R. Clinical prognostic factors in advanced epithelioid haemangioendothelioma: a retrospective series within the Italian Rare Cancers Network. ESMO open 2021;6(2):100083. https://doi.org/10.1016/j.esmoop.2021.100083</mixed-citation><mixed-citation xml:lang="en">Frezza A.M., Napolitano A., Miceli R. Clinical prognostic factors in advanced epithelioid haemangioendothelioma: a retrospective series within the Italian Rare Cancers Network. ESMO open 2021;6(2):100083. https://doi.org/10.1016/j.esmoop.2021.100083</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Kollar A., Jones R.L., Stacchiotti S., et al. Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis. Acta Oncol 2017;56(l):88—92. https://doi.org/10.1080/0284186X.2016.1234068</mixed-citation><mixed-citation xml:lang="en">Kollar A., Jones R.L., Stacchiotti S., et al. Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis. Acta Oncol 2017;56(l):88—92. https://doi.org/10.1080/0284186X.2016.1234068</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Schuetze S.M., Ballman K.V., Heise R., et al. A single-arm phase 2 trial of trametinib in patients with locally advanced or metastatic epithelioid hemangioendothelioma. Clin Cancer Res 2024;30(20):4584-4592. https://doi.org/10.1158/1078-0432.CCR-23-3817</mixed-citation><mixed-citation xml:lang="en">Schuetze S.M., Ballman K.V., Heise R., et al. A single-arm phase 2 trial of trametinib in patients with locally advanced or metastatic epithelioid hemangioendothelioma. Clin Cancer Res 2024;30(20):4584-4592. https://doi.org/10.1158/1078-0432.CCR-23-3817</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Yousaf N., Maruzzo M., Judson .1, et al. Systemic treatment options for epithelioid haemangioendothelioma: the Royal Marsden Hospital experience. Anticancer Res 2015;35(l):473—80</mixed-citation><mixed-citation xml:lang="en">Yousaf N., Maruzzo M., Judson .1, et al. Systemic treatment options for epithelioid haemangioendothelioma: the Royal Marsden Hospital experience. Anticancer Res 2015;35(l):473—80</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Pranteda G., Magri F., Muscianese M., et al. The management of pseudomyogenic hemangioendothelioma of the foot: A case report and review of the literature. Dermatol Ther 2018;3l(6):el2725. https://doi.org/10.llll/dth.12725</mixed-citation><mixed-citation xml:lang="en">Pranteda G., Magri F., Muscianese M., et al. The management of pseudomyogenic hemangioendothelioma of the foot: A case report and review of the literature. Dermatol Ther 2018;3l(6):el2725. https://doi.org/10.llll/dth.12725</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Pinet C., Magnan A., Garbe L., et al. Aggressive form of pleural epithelioid haemangioendothelioma: complete response after chemotherapy. Eur RespirJ 1999;14(l):237-8. https://doi.Org/10.1034/j.1399-3003.1999.14a40.x</mixed-citation><mixed-citation xml:lang="en">Pinet C., Magnan A., Garbe L., et al. Aggressive form of pleural epithelioid haemangioendothelioma: complete response after chemotherapy. Eur RespirJ 1999;14(l):237-8. https://doi.Org/10.1034/j.1399-3003.1999.14a40.x</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Stacchiotti S., Provenzano S., Dagrada G., et al. Sirolimus in advanced epithelioid hemangioendothelioma: a retrospective case-series analysis from the italian rare cancer network database. Ann Surg Oncol 2016;23(9):2735-44. https://doi.org/10.1245/sl0434-016-5331-z</mixed-citation><mixed-citation xml:lang="en">Stacchiotti S., Provenzano S., Dagrada G., et al. Sirolimus in advanced epithelioid hemangioendothelioma: a retrospective case-series analysis from the italian rare cancer network database. Ann Surg Oncol 2016;23(9):2735-44. https://doi.org/10.1245/sl0434-016-5331-z</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Stacchiotti S., Simeone N., Lo Vullo S., et al. Activity of sirolimus in patients with progressive epithelioid hemangioendothelioma: A case-series analysis within the Italian Rare Cancer Network. Cancer 2021;127(4):569-576. https://doi.org/10.1002/cncr.33247</mixed-citation><mixed-citation xml:lang="en">Stacchiotti S., Simeone N., Lo Vullo S., et al. Activity of sirolimus in patients with progressive epithelioid hemangioendothelioma: A case-series analysis within the Italian Rare Cancer Network. Cancer 2021;127(4):569-576. https://doi.org/10.1002/cncr.33247</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Stacchiotti S., Miah A.B., Frezza A.M., et al. Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts. ESMO Open 2021;6(3):100170. https://doi.Org/10.1016/j.esmoop.2021.100170</mixed-citation><mixed-citation xml:lang="en">Stacchiotti S., Miah A.B., Frezza A.M., et al. Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts. ESMO Open 2021;6(3):100170. https://doi.Org/10.1016/j.esmoop.2021.100170</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Двораковская И.В., Бугров C.H., Новикова A.H., и соавт. Эпителиоидная гемангиоэндотелиома легких. Архив патологии 2022;84(2):29-35. https://doi.org/10.17116/patol20228402129.</mixed-citation><mixed-citation xml:lang="en">Dvorakovskaya I.V., Bugrov S.N., Novikova L.N., et al. Pulmonary epithelioid hemangioendothelioma. Russian Journal of Archive of Pathology 2022;84(2):29-35. (In Russ.) https://doi.org/10.17116/patol20228402129</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Коробкова И.З., Дрёмин Д.А., Какалов C.M., и соавт. Эпителиоидная гемангиоэндотелиома печени. Вестник рентгенологии и радиологии 2019;100(6):372-8. https://doi.org/10.20862/0042-4676-2019-100-6-372-378</mixed-citation><mixed-citation xml:lang="en">Korobkova I.Z., Dremin D.A., Kakalov S.M., et al. Hepatic epithelioid hemangioendothelioma. Journal of radiology and nuclear medicine 2019;100(6):372-378 (In Russ.), https://doi.org/10.20862/0042-4676-2019-100-6-372-378</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Кузнецов M.C., Воронов A.B., Савелло A.B., и соавт. Клинический случай диагностики и лечения эпителиоидной гемангиоэндотелиомы синоназальной локализации. Еолова и шея. Российский журнал = Head and neck Russian Journal 2020;8(2):59-64.</mixed-citation><mixed-citation xml:lang="en">Kuznecov M.S., Voronov A.V., Savello A.V., et al. Diagnosis and treatment of epitelioid hemangioedothelioma of synonasal localization: clinical case. Head and neck Russian Journal 2020;8(2):59-64 (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Бакотина A.B., Кабардиев C.P., Журавлева A.B., и соавт. Редкий клинический случай эпителиоидной гемангиоэндотелиомы полости носа. Российская ринология. 2022;30(4):282-287. https://doi.org/10.17116/rosrino202230041282.</mixed-citation><mixed-citation xml:lang="en">Bakotina A.V., Kabardiev S.R., Zhuravleva A.V., et al. A rare clinical case of nasal cavity epithelioid hemangioendothelioma. Russian Rhinology 2022;30(4):282-287 (In Russ.), https://doi.org/10.17116/rosrino202230041282</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Денисов C.H., Еорган H.B., Майоров A.E., и соавт. Злокачественная эпителиоидная гемангиоэндотелиома мягких тканей правого бедра (клинический случай). Поволжский онкологический вестник 2024;15(1):125—131. https://doi.org/10.32000/2078-1466-2024-l-125-131.</mixed-citation><mixed-citation xml:lang="en">Denisov S.N., Gorgan I.V., Mayorov A.E., et al. Malignant epithelioid hemangioendotheliom of soft tissue of the right thigh (clinical case). Oncology Bulletin of the Volga Region 2024;15(l):125—131 (In Russ.), https://doi.org/10.32000/2078-1466-2024-1-125-131</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Колчева M.A., Кумирова Э.В., Лившиц M.H., и соавт. Клинический случай первичной множественной гемангиоэндотелиомы у ребенка с поражением центральной нервной системы. Российский журнал детской гематологии и онкологии (РЖДЕиО) 2022;9(4):88-95. https://doi.org/10.21682/2311-1267-2022-9-4-88-95.</mixed-citation><mixed-citation xml:lang="en">Kolcheva М.А., Kumirova E.V., Livshits M.I., et al. Clinical case of primary multiple hemangioendothelioma in a child with CNS lesions. Russian Journal of Pediatric Hematology and Oncology 2022;9(4):88—95 (In Russ.). https://doi.org/10.21682/2311-1267-2022-9-4-88-95</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
